Liver International: Vol 45, No 8

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Liver International

Journal list menu

Tools

Follow journal

Liver International: Volume 45, Issue 8

Download PDFs

ISSUE INFORMATION

Issue Information

LETTER TO THE EDITOR

Response to: Alcohol Cessation as a Multidisciplinary Imperative in Liver Cancer Survivorship: Clinical and Psychosocial Considerations

Alcohol Cessation as a Multidisciplinary Imperative in Liver Cancer Survivorship: Clinical and Psychosocial Considerations

Exploring Genetic and Clinical Implications of Methylprednisolone-Induced Liver Injury

Reply to ‘Methodological Considerations and Future Directions in Cardiac Geometry Assessment for Cirrhotic Cardiomyopathy’

Methodological Considerations and Future Directions in Cardiac Geometry Assessment for Cirrhotic Cardiomyopathy

Commentary on ‘Rationalising Hepatocellular Carcinoma Screening in Chronic Hepatitis B: Evaluation of Predictive Scores in an Australian Cohort’

Rationalising Hepatocellular Carcinoma Screening in Chronic Hepatitis B: Evaluation of Predictive Scores in an Australian Cohort

Response to: Refining HCC Risk Stratification in CHB: Evaluating Predictive Model Applicability in Diverse Populations

RESEARCH LETTER

MASLD and CMRFs: Combination or Separation? An Open Exploration From the Perspective of All-Cause Mortality

ORIGINAL ARTICLE

Cost-Effectiveness of Hepatitis C Virus Case Finding and Treatment in Eastern Europe and Central Asia

LETTER TO THE EDITOR

Cardiac Geometry in Cirrhosis: Translation to Public Health and Trial Design

NSBBs, EBL or Combined Therapy for High-Risk Varices: Systematic Review and Meta-Analysis

ORIGINAL ARTICLE

Association of Plasma Lipoprotein(a) With Major Adverse Cardiovascular Events in MASLD With or Without Advanced Liver Fibrosis

LETTER TO THE EDITOR

Enhancing HF-DL Model Validation for Liver Fibrosis Staging Through Sample Optimisation and Technical Integration

A Deep Learning Model Based on High-Frequency Ultrasound Images for Classification of Different Stages of Liver Fibrosis

RETRACTION

RETRACTION: Interferons α, β, γ Each Inhibit Hepatitis C Virus Replication at the Level of Internal Ribosome Entry Site-Mediated Translation

RETRACTED: Interferons α, β, γ each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation

RETRACTED: Correction to Interferons Alpha, Beta, Gamma Each Inhibit HCV Replication at the Level of Internal Ribosome Entry Site-Mediated Translation

LETTER TO THE EDITOR

Deciphering the HBV-ALF Paradox: Immune-Viral Crosstalk and Angiogenic Signalling in Spontaneous Survival

Hepatitis B Virus Variants and Cytokine Patterns in Acute Liver Failure and Transplant-Free Survival

Methodological Considerations for Assessing the Long-Term Impact of Maternal MASLD on Offspring Health

Mortality and Cancer in Offspring of Mothers With Biopsy-Proven MASLD During Pregnancy: A Nationwide Cohort Study

Response: Methodological Considerations for Assessing the Long-Term Impact of Maternal MASLD on Offspring Health

REVIEW

Pathogenesis, Non-Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases

ORIGINAL ARTICLE

Odevixibat for Episodic Intrahepatic Cholestasis due to Biallelic Mutations in ATP8B1: A Case Series

Vascular Invasion Within the Resectability Criteria Is a Prognostic Factor in Patients Treated With Atezolizumab and Bevacizumab

TIPS Is Superior to SEMS in the Management of Refractory VARICEAL Bleed in Advanced Cirrhosis Patients (TIPSEMS-VB Trial)

TIPSEMS-VB Trial Reappraised: Infection Control, HE Prophylaxis, and Ischemic Hepatitis Considerations

Burden, Trends, and Projections of Alcohol-Associated Liver Disease and Alcohol Use Disorder in the Asia-Pacific Region 1990–2040

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial

Sunitinib in Advanced Intrahepatic Cholangiocarcinoma: Questions on Biomarkers, Imaging, and Combination Strategies

LETTER TO THE EDITOR

On Challenges of Studying the Complex Role of Bile Acids in Alcohol-Related Liver Disease

Unravelling the Complex Role of Glycine-Conjugated Bile Acids and Gut-Liver Axis in Progressive Alcohol-Related Liver Disease

ORIGINAL ARTICLE

Platelet-Induced NET in Liver Cirrhosis: Mitochondrial ROS-Mediated NETosis and Its Contribution to the Hypercoagulable State

Chronic Nanoplastic Exposure Promotes the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

Nanoplastics and MASLD: Unveiling Interorgan Crosstalk and Environmental Modulators

LETTER TO THE EDITOR

Unpacking the ‘Four-Support’ Model: Towards Contextual Adaptation in HCV Care Cascade

A Multifaceted Approach Leads to Improved Linkage to HCV Therapy: A Multicenter Randomised Controlled Trial

IgG Baseline Serum Levels and Prognosis of Primary Biliary Cholangitis

The Prognostic Role of Increased IgG Levels in Non-Cirrhotic PBC: A Need for Cautious Interpretation

Rationalising Hepatocellular Carcinoma Screening in Chronic Hepatitis B: Evaluation of Predictive Scores in an Australian Cohort

ORIGINAL ARTICLE

Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel

LETTER TO THE EDITOR

Response to: Refining HCC Risk Stratification in CHB: Evaluating Predictive Model Applicability in Diverse Populations

Commentary on ‘Rationalising Hepatocellular Carcinoma Screening in Chronic Hepatitis B: Evaluation of Predictive Scores in an Australian Cohort’

ORIGINAL ARTICLE

Comparative Efficacy of Treatment Regimens for Chronic Hepatitis D Virus Infection: A Systematic Review and Network Meta-Analysis

REVIEW

Liver Involvement in Celiac Disease and Immune-Mediated Diseases of the Small Bowel

LETTER TO THE EDITOR

Ursodeoxycholic Acid: Not Just a Marker, but a Therapeutic Opportunity in Cholestatic CHILI

Challenges of UDCA Monotherapy for CHILI: High Recurrence Rate of Bile Duct Injury With Potential Immune Interference

Response: Methodological Considerations for Assessing the Long-Term Impact of Maternal MASLD on Offspring Health

Methodological Considerations for Assessing the Long-Term Impact of Maternal MASLD on Offspring Health

Expanding the Bile Acid–Neutrophil Axis: Gut Microbiome and Sex-Dimorphism in Post-Cholecystectomy MAFLD

HFD Exacerbates Hepatic Lipid Metabolism Disorders After Cholecystectomy by Regulating the Bile Acid and Neutrophil Recruitment

Dual-Pathway Targeting in Liver Fibrosis: Exploring the Metabolic Implications of HSC Reprogramming

Amelioration of Liver Fibrosis via In Situ Hepatic Stellate Cell Conversion Through Co-Inhibition of TGF-β and GSK-3 Signalling